Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy

Abstract Nanobodies (Nbs) hold great potential to replace conventional antibodies in various biomedical applications. However, conventional methods for their discovery can be time-consuming and expensive. We have developed a reliable protein selection strategy that combines magnetic activated cell s...

Full description

Saved in:
Bibliographic Details
Main Authors: Apisitt Thaiprayoon, Yodpong Chantarasorn, Worrapoj Oonanant, Anongnard Kasorn, Phoomintara Longsompurana, Satita Tapaneeyakorn, Pinpunya Riangrungroj, Fabien Loison, Andrew C. Kruse, Matthew P. DeLisa, Dujduan Waraho-Zhmayev
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-88032-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571781126291456
author Apisitt Thaiprayoon
Yodpong Chantarasorn
Worrapoj Oonanant
Anongnard Kasorn
Phoomintara Longsompurana
Satita Tapaneeyakorn
Pinpunya Riangrungroj
Fabien Loison
Andrew C. Kruse
Matthew P. DeLisa
Dujduan Waraho-Zhmayev
author_facet Apisitt Thaiprayoon
Yodpong Chantarasorn
Worrapoj Oonanant
Anongnard Kasorn
Phoomintara Longsompurana
Satita Tapaneeyakorn
Pinpunya Riangrungroj
Fabien Loison
Andrew C. Kruse
Matthew P. DeLisa
Dujduan Waraho-Zhmayev
author_sort Apisitt Thaiprayoon
collection DOAJ
description Abstract Nanobodies (Nbs) hold great potential to replace conventional antibodies in various biomedical applications. However, conventional methods for their discovery can be time-consuming and expensive. We have developed a reliable protein selection strategy that combines magnetic activated cell sorting (MACS)-based screening of yeast surface display (YSD) libraries and functional ligand-binding identification by Tat-based recognition of associating proteins (FLI-TRAP) to isolate antigen-specific Nbs from synthetic libraries. This combined process enabled isolation of three unique Nb clones (NbT15, NbT21, and NbT22) that all bound specifically to a target antigen, namely proprotein convertase subtilisin/kexin type 9 (PCSK9) as well as a gain-of-function PCSK9 mutant (D374Y). All three clones bound to PCSK9 and blocked the interaction between the low-density lipoprotein receptor (LDLR) and either wild-type PCSK9 or the D374Y mutant. Overall, our combined protein selection method enables rapid and straightforward identification of potent antigen-specific Nbs in a manner that can be executed in a basic laboratory setting without the need for specialized equipment. We anticipate that our strategy will be a valuable addition to the protein engineering toolkit, allowing development of Nbs or virtually any other synthetic binding protein for a wide range of applications.
format Article
id doaj-art-3ccda0e69ac942d3a9d2c92b7dc0447d
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-3ccda0e69ac942d3a9d2c92b7dc0447d2025-02-02T12:19:14ZengNature PortfolioScientific Reports2045-23222025-01-0115111410.1038/s41598-025-88032-1Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategyApisitt Thaiprayoon0Yodpong Chantarasorn1Worrapoj Oonanant2Anongnard Kasorn3Phoomintara Longsompurana4Satita Tapaneeyakorn5Pinpunya Riangrungroj6Fabien Loison7Andrew C. Kruse8Matthew P. DeLisa9Dujduan Waraho-Zhmayev10Biological Engineering Program, Faculty of Engineering, King Mongkut’s University of Technology ThonburiDivision of Ophthalmology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj UniversityDepartment of Basic Medical Science, Faculty of Medicine Vajira Hospital, Navamindradhiraj UniversityDepartment of Basic Medical Science, Faculty of Medicine Vajira Hospital, Navamindradhiraj UniversityBiological Engineering Program, Faculty of Engineering, King Mongkut’s University of Technology ThonburiNational Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA)National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and TechnologyDevelopment Agency (NSTDA)Department of Microbiology, Faculty of Science, Mahidol UniversityDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical SchoolRobert F. Smith School of Chemical and Biomolecular Engineering, Cornell UniversityBiological Engineering Program, Faculty of Engineering, King Mongkut’s University of Technology ThonburiAbstract Nanobodies (Nbs) hold great potential to replace conventional antibodies in various biomedical applications. However, conventional methods for their discovery can be time-consuming and expensive. We have developed a reliable protein selection strategy that combines magnetic activated cell sorting (MACS)-based screening of yeast surface display (YSD) libraries and functional ligand-binding identification by Tat-based recognition of associating proteins (FLI-TRAP) to isolate antigen-specific Nbs from synthetic libraries. This combined process enabled isolation of three unique Nb clones (NbT15, NbT21, and NbT22) that all bound specifically to a target antigen, namely proprotein convertase subtilisin/kexin type 9 (PCSK9) as well as a gain-of-function PCSK9 mutant (D374Y). All three clones bound to PCSK9 and blocked the interaction between the low-density lipoprotein receptor (LDLR) and either wild-type PCSK9 or the D374Y mutant. Overall, our combined protein selection method enables rapid and straightforward identification of potent antigen-specific Nbs in a manner that can be executed in a basic laboratory setting without the need for specialized equipment. We anticipate that our strategy will be a valuable addition to the protein engineering toolkit, allowing development of Nbs or virtually any other synthetic binding protein for a wide range of applications.https://doi.org/10.1038/s41598-025-88032-1Camelid antibodyGenetic selectionHigh-throughput screeningHypercholesterolemiaSynthetic antibody libraryVHH single-domain antibody
spellingShingle Apisitt Thaiprayoon
Yodpong Chantarasorn
Worrapoj Oonanant
Anongnard Kasorn
Phoomintara Longsompurana
Satita Tapaneeyakorn
Pinpunya Riangrungroj
Fabien Loison
Andrew C. Kruse
Matthew P. DeLisa
Dujduan Waraho-Zhmayev
Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy
Scientific Reports
Camelid antibody
Genetic selection
High-throughput screening
Hypercholesterolemia
Synthetic antibody library
VHH single-domain antibody
title Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy
title_full Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy
title_fullStr Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy
title_full_unstemmed Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy
title_short Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy
title_sort isolation of pcsk9 specific nanobodies from synthetic libraries using a combined protein selection strategy
topic Camelid antibody
Genetic selection
High-throughput screening
Hypercholesterolemia
Synthetic antibody library
VHH single-domain antibody
url https://doi.org/10.1038/s41598-025-88032-1
work_keys_str_mv AT apisittthaiprayoon isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy
AT yodpongchantarasorn isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy
AT worrapojoonanant isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy
AT anongnardkasorn isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy
AT phoomintaralongsompurana isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy
AT satitatapaneeyakorn isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy
AT pinpunyariangrungroj isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy
AT fabienloison isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy
AT andrewckruse isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy
AT matthewpdelisa isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy
AT dujduanwarahozhmayev isolationofpcsk9specificnanobodiesfromsyntheticlibrariesusingacombinedproteinselectionstrategy